Try our beta test site
91 studies found for:    rivastigmine
Show Display Options
Rank Status Study
21 Unknown  Cognitive Changes in Alzheimer's Disease Patients Associated With or Without White Matter Changes After Rivastigmine
Condition: Alzheimer's Disease
Intervention: Drug: rivastigmine patch
22 Completed Rivastigmine Capsules in Patients With Probable Vascular Dementia
Condition: Vascular Dementia
Intervention: Drug: Rivastigmine
23 Completed
Has Results
Efficacy and Safety of Rivastigmine Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
24 Active, not recruiting Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI
Conditions: Traumatic Brain Injury;   Cognitive Impairment
Intervention: Drug: Rivastigmine Transdermal Patch
25 Completed
Has Results
16w Interventional Study on Titration and Dose/Efficacy Assessment of Exelon in Chinese Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Intervention: Drug: ENA713
26 Completed Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
27 Completed Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
28 Completed
Has Results
Safety of Switching From Donepezil to Rivastigmine Patch in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 5 cm^2 transdermal patch;   Drug: Rivastigmine 10 cm^2 transdermal patch
29 Terminated Efficacy and Safety of Rivastigmine in Patients With Mild Cognitive Impairment
Condition: Cognitive Symptoms
Intervention: Drug: Rivastigmine
30 Terminated Rivastigmine for Intensive Care Unit (ICU) Delirium
Condition: Delirium
Interventions: Drug: Rivastigmine;   Drug: Placebo
31 Terminated
Has Results
Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Conditions: Multiple Sclerosis;   Cognitive Impairment
Interventions: Drug: Rivastigmine transdermal patch;   Drug: Placebo
32 Completed Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
33 Completed Exelon Patch and Combination With Memantine Comparative Trial
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine transdermal patch (Exelon patch), memantine;   Drug: Rivastigmine transdermal patch
34 Completed
Has Results
The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems
Conditions: Parkinsons Disease With Dementia;   Parkinsons Disease With Mild to Moderate Memory and/or Thinking Problems
Intervention: Drug: Rivastigmine Patch 9.5 cm2
35 Completed
Has Results
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine 4.6 mg/24 h (5 cm^2);   Drug: Rivastigmine 9.5 mg/24 h (10 cm^2);   Drug: Rivastigmine 13.3 mg/24 h (15 cm^2);   Drug: Placebo
36 Completed An Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive Deficits
Condition: Traumatic Brain Injury With Persistent Cognitive Deficits
Intervention: Drug: Rivastigmine
37 Completed
Has Results
A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rivastigmine Patch;   Drug: Rivastigmine Capsules;   Drug: Placebo to Rivastigmine patch;   Drug: Placebo to Rivastigmine capsules
38 Unknown  Efficacy Study for Treatment of Dementia in Progressive Supranuclear Palsy
Conditions: Progressive Supranuclear Palsy;   Dementia
Intervention: Drug: rivastigmine
39 Completed A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal
40 Completed Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia
Condition: Vascular Dementia
Intervention: Drug: Rivastigmine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.